Corporate News
Notice of results - Investor presentation
16 June 2021
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, will issue its financial results for the year ended 31 March 2021 on Tuesday 13 July 2021.
Investor meeting
Colin King and Kieron Harbinson will provide a live presentation relating to the Company’s Final Results via the Investor Meet Company platform on Tuesday 13 July 2021 at 4:30pm BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet OMEGA DIAGNOSTICS GROUP PLC via:
https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor
Investors who already follow OMEGA DIAGNOSTICS GROUP PLC on the Investor Meet Company platform will automatically be invited.
Contacts:
| Omega Diagnostics Group PLC | Tel: 01259 763 030 |
| Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive | www.omegadiagnostics.com |
| Kieron Harbinson, Group Finance Director | |
| finnCap Ltd | Tel: 020 7220 0500 |
| Geoff Nash/Edward Whiley (Corporate Finance) | |
| Alice Lane (ECM) | |
| Walbrook PR Limited | Tel: 020 7933 8780 or [email protected] |
| Paul McManus | Mob: 07980 541 893 |
| Lianne Cawthorne | Mob: 07584 391 303 |
